نتائج البحث - "Sulphonylurea compounds"

1

Oral Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses

المؤلفون: Kamlesh Khunti, John B. Buse, Mette Gislum, Thomas Bo Jensen, Matthew J Crowley, Richard E. Pratley, Christin L. Hertz, Ofri Mosenzon

المصدر: Diabetes Therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74e5615ec6b1eb8d7560050c7cb76f8Test
https://doi.org/10.1007/s13300-020-00994-9Test

2

دورية أكاديمية

Addition of sulphonylurea to metformin does not relevantly change body weight:a prospective observational cohort study (ZODIAC-39)

المؤلفون: Schrijnders, Dennis, Wever, Raiza, Kleefstra, Nanne, Houweling, Sebastiaan T., van Hateren, Kornelis J. J., de Bock, Geertruida H., Bilo, Henk J. G., Groenier, Klaas H., Landman, Gijs W. D.

المصدر: Schrijnders , D , Wever , R , Kleefstra , N , Houweling , S T , van Hateren , K J J , de Bock , G H , Bilo , H J G , Groenier , K H & Landman , G W D 2016 , ' Addition of sulphonylurea to metformin does not relevantly change body weight : a prospective observational cohort study (ZODIAC-39) ' , Diabetes obesity & metabolism , vol. 18 , no. 10 , pp. 973-979 . https://doi.org/10.1111/dom.12700Test

مصطلحات موضوعية: blood glucose, body weight, diabetes mellitus type 2, humans, metformin, prospective studies, sulphonylurea compounds, TYPE-2 DIABETES-MELLITUS, GLYCEMIC CONTROL, CONTROLLED-TRIAL, DOUBLE-BLIND, MASS INDEX, THERAPY, EFFICACY, INSULIN, COMBINATION, MONOTHERAPY

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/524a2d17-bece-487b-aded-926d0f593c92Test

الإتاحة: https://doi.org/10.1111/dom.12700Test
https://hdl.handle.net/11370/524a2d17-bece-487b-aded-926d0f593c92Test
https://research.rug.nl/en/publications/524a2d17-bece-487b-aded-926d0f593c92Test
https://pure.rug.nl/ws/files/40449003/Addition_of_sulphonylurea_to_metformin_does_not_relevantly_change_body_weight.pdfTest

View record in BASE

3

دورية أكاديمية

Oral Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses

المؤلفون: Pratley R.E, Crowley M.J, Gislum M, Hertz C.L, Jensen T.B, Khunti K, Mosenzon O, Buse J.B

المصدر: Diabetes Therapy, 12(4)

مصطلحات موضوعية: Glucagon-like peptides, Insulin, Oral semaglutide, Metformin, Hypoglycaemic agents, Sulphonylurea compounds, Diabetes mellitus, type 2, Sodium-glucose cotransporter 2 inhibitors

العلاقة: https://doi.org/10.17615/b2w6-2e46Test; https://cdr.lib.unc.edu/downloads/m900p5648?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/m900p5648Test

الإتاحة: https://doi.org/10.17615/b2w6-2e46Test
https://cdr.lib.unc.edu/downloads/m900p5648?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/m900p5648Test

View record in BASE

4

صورة

Oral Semaglutide Reduces HbA1c and Body Weight in Patients With Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses

المؤلفون: Adis journals on behalf of (9646730), Richard E. Pratley (7450022), Matthew J. Crowley (6528452), Mette Gislum (9909294), Christin L. Hertz (9909296), Thomas B. Jensen (2527876), Kamlesh Khunti (171607), Ofri Mosenzon (8667308), John B. Buse (7450016)

مصطلحات موضوعية: Medicine, Endocrinology, Diabetes mellitus, type 2, Glucagon-like peptides, Hypoglycaemic agents, Insulin, Metformin, Oral semaglutide, Sodium-glucose cotransporter 2 inhibitors, Sulphonylurea compounds

العلاقة: https://figshare.com/articles/figure/Oral_Semaglutide_Reduces_HbA1c_and_Body_Weight_in_Patients_With_Type_2_Diabetes_Regardless_of_Background_Glucose-Lowering_Medication_PIONEER_Subgroup_Analyses/13477029Test

الإتاحة: https://doi.org/10.6084/m9.figshare.13477029.v1Test

View record in BASE

5

دورية أكاديمية

Agentes farmacológicos actuales en el tratamiento de la diabetes mellitus no insulinodependiente

المؤلفون: Arturo Hernández-Yero, Raquel Jorge González

المصدر: Revista Cubana de Medicina General Integral, Vol 13, Iss 6, Pp 596-609 (1997)

مصطلحات موضوعية: DIABETES MELLITUS NO INSULINO DEPENDIENTE, DIABETES MELLITUS NO INSULINODEPENDIENTE, GLUCOSIDASAS, BIGUANIDAS, ALFAGLUCOSIDASAS, ALFAGLUCOSIDASA, TIAZOLES, COMPUESTOS DE SULFUNILUREA, INSULINA, NON-INSULIN-DEPENDENT DIABETES MELLITUS, GLUCOSIDASES, BIGUADINES, ALPHA-GLUCOSIDASES, THIAZOLES, SULPHONYLUREA COMPOUNDS, INSULIN, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21251997000600014Test; https://doaj.org/toc/0864-2125Test; https://doaj.org/toc/1561-3038Test

الوصول الحر: https://doaj.org/article/2c2166cf685641fb816f595d1d18ce57Test

View record in DOAJ

6

Addition of sulphonylurea to metformin does not relevantly change body weight

المؤلفون: Raiza Wever, Nanne Kleefstra, Dennis Schrijnders, Henk J. G. Bilo, Gijs W. D. Landman, Kornelis J. J. van Hateren, Sebastiaan T. Houweling, Geertruida H. de Bock, Klaas H. Groenier

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Life Course Epidemiology (LCE), Lifestyle Medicine (LM), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

المصدر: Diabetes, Obesity & Metabolism
Diabetes obesity & metabolism, 18(10), 973-979. Wiley

مصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, MONOTHERAPY, Type 2 diabetes, THERAPY, law.invention, DOUBLE-BLIND, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, GLYCEMIC CONTROL, blood glucose, Mass index, 030212 general & internal medicine, Prospective cohort study, humans, Middle Aged, INSULIN, Metformin, Cohort, Original Article, Drug Therapy, Combination, Female, medicine.drug, Cohort study, medicine.medical_specialty, diabetes mellitus type 2, sulphonylurea compounds, TYPE-2 DIABETES-MELLITUS, 030209 endocrinology & metabolism, CONTROLLED-TRIAL, 03 medical and health sciences, body weight, MASS INDEX, Internal medicine, Internal Medicine, medicine, Hypoglycemic Agents, COMBINATION, Aged, Retrospective Studies, Glycated Hemoglobin, business.industry, Type 2 Diabetes Mellitus, Original Articles, medicine.disease, EFFICACY, prospective studies, Surgery, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, business, metformin